Store

Home
Spirit Pharmaceuticals
Ronkonkoma Nov 2023 483

483 Document: Spirit Pharmaceuticals, Nov 1, 2023

Gam S. Zamil, FDA Investigator
Paige R. Mccoy, FDA Investigator

FDANews 483 Spirit Pharmaceuticals Nov 1 2023 top

Gam S. Zamil FDA Investigator Paige R. Mccoy FDA Investigator

On Nov 01, 2023, the FDA inspected Spirit Pharmaceuticals's Ronkonkoma site. Explore the inspectional observations.

Spirit Pharmaceuticals

483 Document

Issued: Nov 1, 2023

Details

Human DrugsInspection
Ronkonkoma / United States
10 days

Available for Download - $199

[email protected]
+1 (650) 646-4996

About

About Us
Terms of Service
Privacy Policy
Support

GMP Resources

FDA Inspections DB

FDA Form 483 Database

Document Review

Related Apps

Quality Regulatory Intelligence

Redica Platform

Formerly FDAzilla, Redica is a data analytics platform built for the life sciences to improve product quality and reduce regulatory risk.

Spectator Sports

BlitzSports

Score Clock App for youth sports parents asked to be time-keeper. This is the scorekeeping of the future.

Copyright © 2007 - 2025 Zymergi, Inc.